Jinyu Bio-technology Co., Ltd. (SHA:600201)

China flag China · Delayed Price · Currency is CNY
14.89
-0.06 (-0.40%)
Mar 9, 2026, 3:00 PM CST
110.01%
Market Cap 16.27B
Revenue (ttm) 1.33B
Net Income (ttm) 100.76M
Shares Out 1.09B
EPS (ttm) 0.10
PE Ratio 154.98
Forward PE 87.59
Dividend 0.03 (0.20%)
Ex-Dividend Date Jun 26, 2025
Volume 24,007,597
Average Volume 29,945,305
Open 14.79
Previous Close 14.95
Day's Range 14.49 - 15.01
52-Week Range 6.50 - 19.00
Beta 0.93
RSI 37.11
Earnings Date Apr 23, 2026

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company operates through three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine influenza bivalent, porcine reproductive and respiratory syndrome, pseudorabies ther... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 1,740
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600201
Full Company Profile

Financial Performance

In 2024, Jinyu Bio-technology's revenue was 1.26 billion, a decrease of -21.45% compared to the previous year's 1.60 billion. Earnings were 108.99 million, a decrease of -61.57%.

Financial Statements

News

There is no news available yet.